A Multicenter Phase II Study on Atezolizumab plus Bevacizumab Combination Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh Classification B Cirrhosis: CHALLENGE Trial.

Saved in:
Bibliographic Details
Title: A Multicenter Phase II Study on Atezolizumab plus Bevacizumab Combination Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh Classification B Cirrhosis: CHALLENGE Trial.
Authors: Terashima T; Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan.; Department of Medical Oncology, Kanazawa Medical University, Uchinada, Japan., Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Yamashita T; Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan., Okusaka T; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan., Imaoka H; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan., Kawaoka T; Department of Gastroenterology, Hiroshima University Hospital, Hiroshima, Japan., Kobayashi S; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan., Ogasawara S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan., Hiraoka A; Department of Gastroenterology, Ehime Prefectural Central Hospital, Matsuyama, Japan., Nakano M; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan., Okano N; Department of Medical Oncology, Kyorin University Faculty of Medicine, Mitaka, Japan., Sugimoto R; Department of Hepato-Biliary-Pancreatology, NHO Kyushu Cancer Center, Fukuoka, Japan., Moriguchi M; Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan., Inaba Y; Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, Nagoya, Japan., Shinoda S; Department of Biostatistics, Yokohama City University, School of Medicine, Yokohama, Japan., Ueno M; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan., Kudo M; Department of Gastroenterology and Hepatology, Kindai University Hospital, Osaka-Sayama, Japan., Furuse J; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan., Nagano H; Department of Gastroenterological, Breast, and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
Source: Liver cancer [Liver Cancer] 2026 Mar 12. Date of Electronic Publication: 2026 Mar 12.
Publication Type: Journal Article
Journal Info: Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101597993 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2235-1795 (Print) Linking ISSN: 16645553 NLM ISO Abbreviation: Liver Cancer
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42158105
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A Multicenter Phase II Study on Atezolizumab plus Bevacizumab Combination Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh Classification B Cirrhosis: CHALLENGE Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Terashima+T%22">Terashima T</searchLink>; Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan.; Department of Medical Oncology, Kanazawa Medical University, Uchinada, Japan.<br /><searchLink fieldCode="AU" term="%22Ikeda+M%22">Ikeda M</searchLink>; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Yamashita+T%22">Yamashita T</searchLink>; Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan.<br /><searchLink fieldCode="AU" term="%22Okusaka+T%22">Okusaka T</searchLink>; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Imaoka+H%22">Imaoka H</searchLink>; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan.<br /><searchLink fieldCode="AU" term="%22Kawaoka+T%22">Kawaoka T</searchLink>; Department of Gastroenterology, Hiroshima University Hospital, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Kobayashi+S%22">Kobayashi S</searchLink>; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Ogasawara+S%22">Ogasawara S</searchLink>; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Hiraoka+A%22">Hiraoka A</searchLink>; Department of Gastroenterology, Ehime Prefectural Central Hospital, Matsuyama, Japan.<br /><searchLink fieldCode="AU" term="%22Nakano+M%22">Nakano M</searchLink>; Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.<br /><searchLink fieldCode="AU" term="%22Okano+N%22">Okano N</searchLink>; Department of Medical Oncology, Kyorin University Faculty of Medicine, Mitaka, Japan.<br /><searchLink fieldCode="AU" term="%22Sugimoto+R%22">Sugimoto R</searchLink>; Department of Hepato-Biliary-Pancreatology, NHO Kyushu Cancer Center, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Moriguchi+M%22">Moriguchi M</searchLink>; Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.<br /><searchLink fieldCode="AU" term="%22Inaba+Y%22">Inaba Y</searchLink>; Diagnostic and Interventional Radiology, Aichi Cancer Center Hospital, Nagoya, Japan.<br /><searchLink fieldCode="AU" term="%22Shinoda+S%22">Shinoda S</searchLink>; Department of Biostatistics, Yokohama City University, School of Medicine, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Ueno+M%22">Ueno M</searchLink>; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Kudo+M%22">Kudo M</searchLink>; Department of Gastroenterology and Hepatology, Kindai University Hospital, Osaka-Sayama, Japan.<br /><searchLink fieldCode="AU" term="%22Furuse+J%22">Furuse J</searchLink>; Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Nagano+H%22">Nagano H</searchLink>; Department of Gastroenterological, Breast, and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101597993%22">Liver cancer</searchLink> [Liver Cancer] 2026 Mar 12. <i>Date of Electronic Publication: </i>2026 Mar 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22S%2E+Karger%22">S. Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101597993 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2235-1795 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216645553%22">16645553 </searchLink><i>NLM ISO Abbreviation: </i>Liver Cancer
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42158105
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000551476
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: A Multicenter Phase II Study on Atezolizumab plus Bevacizumab Combination Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh Classification B Cirrhosis: CHALLENGE Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Terashima T
      – PersonEntity:
          Name:
            NameFull: Ikeda M
      – PersonEntity:
          Name:
            NameFull: Yamashita T
      – PersonEntity:
          Name:
            NameFull: Okusaka T
      – PersonEntity:
          Name:
            NameFull: Imaoka H
      – PersonEntity:
          Name:
            NameFull: Kawaoka T
      – PersonEntity:
          Name:
            NameFull: Kobayashi S
      – PersonEntity:
          Name:
            NameFull: Ogasawara S
      – PersonEntity:
          Name:
            NameFull: Hiraoka A
      – PersonEntity:
          Name:
            NameFull: Nakano M
      – PersonEntity:
          Name:
            NameFull: Okano N
      – PersonEntity:
          Name:
            NameFull: Sugimoto R
      – PersonEntity:
          Name:
            NameFull: Moriguchi M
      – PersonEntity:
          Name:
            NameFull: Inaba Y
      – PersonEntity:
          Name:
            NameFull: Shinoda S
      – PersonEntity:
          Name:
            NameFull: Ueno M
      – PersonEntity:
          Name:
            NameFull: Kudo M
      – PersonEntity:
          Name:
            NameFull: Furuse J
      – PersonEntity:
          Name:
            NameFull: Nagano H
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 03
              Text: 2026 Mar 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2235-1795
          Titles:
            – TitleFull: Liver cancer
              Type: main
ResultId 1